HeMoDe
ActiveSummary
HeMoDe has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €95,267 and a net result of €11,460. Equity is growing by about 31% per year across the filed financial years. Its solvency ranks better than 67% of 20,309 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
11-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 11 days late
2025
31-12
Financial
Weakest financial yearnet €11,460 ▼52.3%
Net result drops to €11,460, the lowest in the series.
19-05
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Liquidity doublescurrent ratio 4.30
Current ratio from 2.12 to 4.30; short-term debt falls from €19,662 to €16,186.
24-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
16-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.